Search
Descriptor English: Idarubicin
Descriptor Spanish: Idarrubicina
Descriptor idarrubicina
Entry term(s) 4-demetoxidaunorrubicina
Scope note: Antraciclina antineoplásica de administración oral. Se ha demostrado que el compuesto tiene actividad frente al CÁNCER DE MAMA, LINFOMAS y LEUCEMIAS.
Descriptor Portuguese: Idarubicina
Descriptor French: Idarubicine
Entry term(s): 4 Demethoxydaunorubicin
4 Desmethoxydaunorubicin
4-Demethoxydaunorubicin
4-Desmethoxydaunorubicin
Hydrochloride, Idarubicin
IMI 30
IMI-30
IMI30
Idarubicin Hydrochloride
NSC 256439
NSC-256439
NSC256439
Tree number(s): D02.455.426.559.847.562.050.200.300
D04.615.562.050.200.300
D09.408.051.059.200.300
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D015255
Scope note: An orally administered anthracycline antineoplastic. The compound has shown activity against BREAST NEOPLASMS; LYMPHOMA; and LEUKEMIA.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Antibiotics, Antineoplastic
Topoisomerase II Inhibitors
Registry Number: ZRP63D75JW
CAS Type 1 Name: 5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-
Previous Indexing: Antibiotics, Antineoplastic (1967-1988)
Daunorubicin/analogs & derivatives (1975-1988)
Public MeSH Note: 89
History Note: 89
DeCS ID: 23687
Unique ID: D015255
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1989/01/01
Date of Entry: 1988/05/17
Revision Date: 2013/07/08
Idarubicin - Preferred
Concept UI M0023493
Scope note An orally administered anthracycline antineoplastic. The compound has shown activity against BREAST NEOPLASMS; LYMPHOMA; and LEUKEMIA.
Preferred term Idarubicin
Entry term(s) 4 Demethoxydaunorubicin
4 Desmethoxydaunorubicin
4-Demethoxydaunorubicin
4-Desmethoxydaunorubicin
IMI-30 - Narrower
Concept UI M0023494
Preferred term IMI-30
Entry term(s) IMI 30
IMI30
NSC-256439 - Narrower
Concept UI M0350672
Preferred term NSC-256439
Entry term(s) NSC 256439
NSC256439
Idarubicin Hydrochloride - Narrower
Concept UI M0023495
Preferred term Idarubicin Hydrochloride
Entry term(s) Hydrochloride, Idarubicin



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey